🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

Stocks - Disney, Novavax Soar Premarket; Nikola Slumps

Published 2020-08-05, 08:03 a/m
© Reuters.
DIS
-
AAPL
-
AMZN
-
XOM
-
WMT
-
CVS
-
NVAX
-
WW
-
REGN
-
SQ
-
TWLO
-
BYND
-
NKLA
-

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Wednesday, August 5th. Please refresh for updates.

  • Walt Disney (NYSE:DIS) stock rose 6.6% after the entertainment giant surprised with a quarterly adjusted profit despite the Covid-19 pandemic shutting its parks and movie theaters. The company took a nearly $5 billion charge, but reported 54.5 million subscribers as of May 4 for its Disney+ streaming service.

  • Square (NYSE:SQ) stock rose 10% after the payments processor reported on Tuesday a 64% jump in second-quarter revenue as consumers increased online buying and used its peer-to-peer Cash App platform during the Covid-19 pandemic.

  • Exxon Mobil (NYSE:XOM) stock rose 2% with the oil giant set to announce plans to cut costs by suspending the employer match to retirement savings plans beginning in early October, Reuters reported.

  • Apple (NASDAQ:AAPL) stock fell 0.3% after Bank of America downgraded its investment stance on the iPhone maker to “neutral”, citing a slowdown in sales growth of these phones. 

  • Nikola (NASDAQ:NKLA) stock fell over 14% after the electric-vehicle maker reported wider than expected second-quarter loss after hours Tuesday, saying the pandemic had disrupted its supply chain.

  • Novavax (NASDAQ:NVAX) stock rose 22% after the biotech said its potential vaccine to prevent Covid-19 generated a promising immune response in an early stage clinical trial.

  • Beyond Meat (NASDAQ:BYND) stock fell 7.2% as additional costs incurred because of the pandemic widened the plant-based burger maker’s quarterly net loss to $10.2 million from $9.4 million, even as sales surged 69%.

  • WW International (NASDAQ:WW) stock fell 8% after the company, formerly known as Weight Watchers, reported a 10% drop in revenues in the second quarter despite subscribers climbing to an all-time high in the quarter.

  • CVS (NYSE:CVS) stock rose 2.5% as the drugstore chain lifted its guidance for the full-year after reporting strong second quarter earnings.

  • Twilio (NYSE:TWLO) stock dropped 4.1% after the software company reported slowing sales growth, stoking concerns that corporate demand for communications tools may ease in the future

  • Walmart (NYSE:WMT) stock fell 0.9% after the retail giant delayed the launch of its paid membership service, Walmart Plus, once more, according to a report from Recode. Walmart is aiming for this service to be a competitor to Amazon (NASDAQ:AMZN) Prime.

  • Regeneron (NASDAQ:REGN) stock rose 3.3% after beating second-quarter profit estimates, helped by higher sales of its blockbuster eczema treatment Dupixent.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.